The law under consideration “delinks” PBM compensation from manufacturer rebates in Medicare and requires flat administrative fees, certified at fair market value. It also mandates that rebates be passed through to health plan sponsors in the employer-sponsored market. This sounds appealing, but incentives matter. When compensation no longer depends on securing better terms, bargaining effort becomes a cost center rather than a profit center. PBMs will still compete for contracts, but competition on administrative fees isn’t the same as competition on aggressive price concessions and won’t lower drug prices.
Gemini's output seemed taken from science fiction, with a "sentient AI wife, humanoid robots, federal manhunt, and terrorist operations," the lawsuit said. Gavalas is said to have spent several days following Gemini's instructions on "missions" that ultimately harmed no one but himself.
。关于这个话题，heLLoword翻译官方下载提供了深入分析
В США объяснили провал «Леопардов» на Украине02:03。wps下载是该领域的重要参考
СюжетМинобороны